These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

710 related articles for article (PubMed ID: 28543086)

  • 1. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis.
    Dhami S; Kakourou A; Asamoah F; Agache I; Lau S; Jutel M; Muraro A; Roberts G; Akdis CA; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci Ö; Mosges R; Palomares O; Pfaar O; Smolinska S; Sokolowska M; Asaria M; Netuveli G; Zaman H; Akhlaq A; Sheikh A
    Allergy; 2017 Dec; 72(12):1825-1848. PubMed ID: 28543086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen immunotherapy for allergic rhinoconjunctivitis: A systematic review and meta-analysis.
    Dhami S; Nurmatov U; Arasi S; Khan T; Asaria M; Zaman H; Agarwal A; Netuveli G; Roberts G; Pfaar O; Muraro A; Ansotegui IJ; Calderon M; Cingi C; Durham S; van Wijk RG; Halken S; Hamelmann E; Hellings P; Jacobsen L; Knol E; Larenas-Linnemann D; Lin S; Maggina P; Mösges R; Oude Elberink H; Pajno G; Panwankar R; Pastorello E; Penagos M; Pitsios C; Rotiroti G; Timmermans F; Tsilochristou O; Varga EM; Schmidt-Weber C; Wilkinson J; Williams A; Worm M; Zhang L; Sheikh A
    Allergy; 2017 Nov; 72(11):1597-1631. PubMed ID: 28493631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does evidence support the use of cat allergen immunotherapy?
    Dhami S; Agarwal A
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):350-355. PubMed ID: 29870462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: A systematic overview.
    Asaria M; Dhami S; van Ree R; Gerth van Wijk R; Muraro A; Roberts G; Sheikh A
    Allergy; 2018 Feb; 73(2):269-283. PubMed ID: 28718981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy for IgE-mediated food allergy: a systematic review and meta-analysis.
    Nurmatov U; Dhami S; Arasi S; Pajno GB; Fernandez-Rivas M; Muraro A; Roberts G; Akdis C; Alvaro-Lozano M; Beyer K; Bindslev-Jensen C; Burks W; du Toit G; Ebisawa M; Eigenmann P; Knol E; Makela M; Nadeau KC; O'Mahony L; Papadopoulos N; Poulsen LK; Sackesen C; Sampson H; Santos AF; van Ree R; Timmermans F; Sheikh A
    Allergy; 2017 Aug; 72(8):1133-1147. PubMed ID: 28058751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sublingual versus subcutaneous immunotherapy in children with allergic rhinitis: a systematic review and meta-analysis.
    Yang J; Lei S
    Front Immunol; 2023; 14():1274241. PubMed ID: 38162647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review.
    Chelladurai Y; Suarez-Cuervo C; Erekosima N; Kim JM; Ramanathan M; Segal JB; Lin SY
    J Allergy Clin Immunol Pract; 2013; 1(4):361-9. PubMed ID: 24565541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for Experimental Allergen Immunotherapy: Subcutaneous and Sublingual Desensitization in Mouse Models of Allergic Asthma.
    Hesse L; Petersen AH; Nawijn MC
    Methods Mol Biol; 2021; 2223():295-335. PubMed ID: 33226602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EAACI Guidelines on Allergen Immunotherapy: House dust mite-driven allergic asthma.
    Agache I; Lau S; Akdis CA; Smolinska S; Bonini M; Cavkaytar O; Flood B; Gajdanowicz P; Izuhara K; Kalayci O; Mosges R; Palomares O; Papadopoulos NG; Sokolowska M; Angier E; Fernandez-Rivas M; Pajno G; Pfaar O; Roberts GC; Ryan D; Sturm GJ; van Ree R; Varga EM; van Wijk RG; Yepes-Nuñez JJ; Jutel M
    Allergy; 2019 May; 74(5):855-873. PubMed ID: 31095767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What you should not miss from the systematic reviews and meta-analyses on allergen-specific immunotherapy in 2017.
    Larenas-Linnemann D; Luna-Pech JA
    Curr Opin Allergy Clin Immunol; 2018 Jun; 18(3):168-176. PubMed ID: 29629956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous immunotherapy suppresses Th2 inflammation and induces neutralizing antibodies, but sublingual immunotherapy suppresses airway hyperresponsiveness in grass pollen mouse models for allergic asthma.
    Hesse L; Brouwer U; Petersen AH; Gras R; Bosman L; Brimnes J; Oude Elberink JNG; van Oosterhout AJM; Nawijn MC
    Clin Exp Allergy; 2018 Aug; 48(8):1035-1049. PubMed ID: 29752757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergen immunotherapy for allergic asthma: a systematic overview of systematic reviews.
    Asamoah F; Kakourou A; Dhami S; Lau S; Agache I; Muraro A; Roberts G; Akdis C; Bonini M; Cavkaytar O; Flood B; Izuhara K; Jutel M; Kalayci Ö; Pfaar O; Sheikh A
    Clin Transl Allergy; 2017; 7():25. PubMed ID: 28775845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
    Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
    J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous and Sublingual Immunotherapy in a Mouse Model of Allergic Asthma.
    Hesse L; Nawijn MC
    Methods Mol Biol; 2017; 1559():137-168. PubMed ID: 28063043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen immunotherapy in asthma.
    Nakagome K; Nagata M
    Allergol Int; 2024 Oct; 73(4):487-493. PubMed ID: 38955611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses.
    Tie K; Miller C; Zanation AM; Ebert CS
    Laryngoscope; 2022 Mar; 132(3):499-508. PubMed ID: 33929726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How can we improve our use of allergen immunotherapy as a treatment option for asthma and severe asthma?
    Larenas-Linnemann D; Morfin Maciel BM
    Expert Rev Respir Med; 2023; 17(8):717-725. PubMed ID: 37642332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House Dust Mite Sublingual Immunotherapy for Pediatric Patients With Allergic Asthma.
    Richards JR; Stumpf JL
    Ann Pharmacother; 2018 Oct; 52(10):1019-1030. PubMed ID: 29642713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of allergen-specific immunotherapy in children.
    De Filippo M; Votto M; Caminiti L; Panasiti I; Carella F; De Castro G; Landi M; Olcese R; Vernich M; Marseglia GL; Ciprandi G; Barberi S
    Pediatr Allergy Immunol; 2022 Jan; 33 Suppl 27(Suppl 27):27-30. PubMed ID: 35080302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.